CodeMap® 

150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2021
2020 (July)

Physician Fee Schedule

2021
2020

OPPS Fee Schedule

2021-April
2021-January

ASC Fee Schedule

2021-April
2021-January

APC Codes

2021-April
2021-January

DRG Codes

2021
2020

ASP Drug Pricing Files

April 2021
January 2021


CMS Transmittals




Next Webinar 05/19/2021:
How to Structure Financial Arrangements with Customers

CodeMap® LCD-L37630

 

Printer Friendly Version

L37630
LCD for In Vitro Chemosensitivity & Chemoresistance Assays (L37630)
See related Articles:
A56073-Billing and Coding: In Vitro Chemosensitivity & Chemoresistance Assays
A56077-Response to Comments: In Vitro Chemosensitivity & Chemoresistance Assays

Contractor Information

Contractor Name: Noridian Healthcare Solutions, LLC - Full list of policies of this Medicare Contractor

Contractor Number: 02401

Contractor Type: MAC A

LCD Information

LCD ID Number: L37630 Status: A-Approved

LCD Title: In Vitro Chemosensitivity & Chemoresistance Assays

Geographic Jurisdiction: Washington Other Jurisdictions

Original Determination Effective Date: 10/01/2018

Original Determination Ending Date:

Revision Effective Date: 02/25/2020

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act, §1862(a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Title XVIII of the Social Security Act, §1862(a)(1)(D) addresses items and services related to research and experimentation.

Title XVIII of the Social Security Act, §1862(a)(7) excludes routine physical examinations.

42 CFR §410.32 Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions.

CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 3, §190.7 Human Tumor Stem Cell Drug Sensitivity Assays

CMS Internet-Only Manual, Pub 100-08, Medicare Program Integrity Manual, Chapter 3, §3.2.3.7  Special Provisions for Lab Additional Documentation Requests


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*
All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

05/10/2021 10:18:58 3.226.72.118


CodeMap® is a Registered Trademark of Wheaton Partners, LLC.